The global corifollitropin alfa market is anticipated to grow at a significant CAGR during the forecast period. Corifollitropin alfa is a hybrid follicle stimulating hormone (FSH) molecule, which is utilized to treat infertility. The molecule when infused results in the development of a high number of metaphase II oocytes in women. The primary factor that contributes to the growth of the market is the high incidence of infertility in young population owing to several underlying causes such as polycystic ovary syndrome (PCOS) or the occurrence of blockage in the fallopian tube. As per the World Health Organization (WHO), infertility affects millions of people of reproductive age all over the globe and has an impact on their families and communities. Estimates suggest that between 48 million couples and 186 million individuals live with infertility all over the globe – as per the estimates of September 2020.
Further, a substantial growth in the number of fertility clinics, rising awareness about infertility treating hormones among the global population, coupled with the technological advancements in the healthcare sector are also likely to propel the market growth. However, high cost of infertility treatments may hinder the market growth. The improvement in corifollitropin alfa efficacy for in vitro fertilization will further boost the market growth.
To Request a Sample of our Report on Corifollitropin Alfa Market: https://www.omrglobal.com/request-sample/corifollitropin-alfa-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
Segment Covered-
- By Application
- By Deployment Model
- By End-User
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Merck & Co., Inc., and Schering-Plough Corp., among others.
Corifollitropin Alfa Market Report by Segment
By Type
- Industrial Grade
- Pharmaceutical Grade
By End-User
- Hospitals
- Laboratories
A full Report of Corifollitropin Alfa Market is Available @ https://www.omrglobal.com/industry-reports/corifollitropin-alfa-market
Corifollitropin Alfa Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East and Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/corifollitropin-alfa-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
